18.30
-0.19 (-1.03%)
| Penutupan Terdahulu | 18.49 |
| Buka | 18.24 |
| Jumlah Dagangan | 231,492 |
| Purata Dagangan (3B) | 380,857 |
| Modal Pasaran | 6,497,925,632 |
| Harga / Pendapatan (P/E Ke hadapan) | 16.92 |
| Harga / Jualan (P/S) | 1.25 |
| Harga / Buku (P/B) | 0.990 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 29 Apr 2026 |
| Margin Keuntungan | -7.50% |
| Margin Operasi (TTM) | -5.36% |
| EPS Cair (TTM) | -1.02 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 3.50% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 75.07% |
| Nisbah Semasa (MRQ) | 1.56 |
| Aliran Tunai Operasi (OCF TTM) | 166.00 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 69.00 M |
| Pulangan Atas Aset (ROA TTM) | 0.61% |
| Pulangan Atas Ekuiti (ROE TTM) | -5.36% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Instruments & Supplies (US) | Bercampur | Bercampur |
| Medical Instruments & Supplies (Global) | Bercampur | Menurun | |
| Stok | Bausch + Lomb Corporation | Menaik | Menaik |
AISkor Stockmoo
| Konsensus Penganalisis | 1.5 |
| Aktiviti Orang Dalam | 0.5 |
| Volatiliti Harga | -3.5 |
| Purata Bergerak Teknikal | 1.5 |
| Osilator Teknikal | -0.5 |
| Purata | -0.10 |
|
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space. |
|
| Sektor | Healthcare |
| Industri | Medical Instruments & Supplies |
| Gaya Pelaburan | Mid Core |
| % Dimiliki oleh Orang Dalam | 88.13% |
| % Dimiliki oleh Institusi | 10.97% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Caspian Capital Lp | 31 Dec 2025 | 1,999,043 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 21.00 (Citigroup, 14.75%) | Beli |
| Median | 19.00 (3.83%) | |
| Rendah | 16.00 (Stifel, -12.57%) | Pegang |
| Purata | 18.83 (2.90%) | |
| Jumlah | 2 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 17.57 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| HC Wainwright & Co. | 23 Feb 2026 | 20.00 (9.29%) | Beli | 17.99 |
| Barclays | 19 Feb 2026 | 20.00 (9.29%) | Pegang | 17.65 |
| Citigroup | 19 Feb 2026 | 21.00 (14.75%) | Beli | 17.65 |
| Stifel | 19 Feb 2026 | 16.00 (-12.57%) | Pegang | 17.65 |
| 17 Feb 2026 | 15.00 (-18.03%) | Pegang | 17.73 | |
| Wells Fargo | 19 Feb 2026 | 18.00 (-1.64%) | Pegang | 17.65 |
| Evercore ISI Group | 05 Jan 2026 | 18.00 (-1.64%) | Pegang | 16.80 |
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BAILEY A ROBERT D | 17.06 | - | 29,200 | 498,152 |
| ELDESSOUKY SAM | 17.06 | - | 8,000 | 136,480 |
| ROSS THOMAS W. SR. | 17.98 | - | 9,000 | 161,820 |
| SAUNDERS BRENT L | 17.06 | - | 29,400 | 501,564 |
| Jumlah Keseluruhan Kuantiti Bersih | 75,600 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | 1,298,016 | |||
| Purata Pembelian Keseluruhan ($) | 17.29 | |||
| Purata Jualan Keseluruhan ($) | - | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| SAUNDERS BRENT L | Pegawai | 06 Mar 2026 | Beli (+) | 14,700 | 17.06 | 250,782 |
| SAUNDERS BRENT L | Pegawai | 06 Mar 2026 | Diperolehi (+) | 14,700 | 17.06 | 250,782 |
| ELDESSOUKY SAM | Pegawai | 06 Mar 2026 | Beli (+) | 4,000 | 17.06 | 68,240 |
| ELDESSOUKY SAM | Pegawai | 06 Mar 2026 | Diperolehi (+) | 4,000 | 17.06 | 68,240 |
| BAILEY A ROBERT D | Pegawai | 06 Mar 2026 | Beli (+) | 14,600 | 17.06 | 249,076 |
| BAILEY A ROBERT D | Pegawai | 06 Mar 2026 | Diperolehi (+) | 14,600 | 17.06 | 249,076 |
| ROSS THOMAS W. SR. | Pengarah | 03 Mar 2026 | Beli (+) | 4,500 | 17.98 | 80,910 |
| ROSS THOMAS W. SR. | Pengarah | 03 Mar 2026 | Diperolehi (+) | 4,500 | 17.98 | 80,910 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 23 Jan 2026 | Pengumuman | Bausch Health Provides Update on RED-C Phase 3 Clinical Trials |
| 21 Jan 2026 | Pengumuman | Bausch Health to Announce Fourth Quarter and Full Year 2025 Results on February 18, 2026 |
| 20 Jan 2026 | Pengumuman | Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2025 Financial Results on Feb. 18 |
| 05 Jan 2026 | Pengumuman | Bausch Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference |
| 05 Jan 2026 | Pengumuman | Bausch + Lomb Partners with Glaucoma Research Foundation and The Glaucoma Foundation to Address a Leading Cause of Irreversible Blindness in the U.S. |
| 02 Jan 2026 | Pengumuman | Bausch + Lomb Completes Refinancing of Outstanding Term B Loans |
| 23 Dec 2025 | Pengumuman | Bausch Health Announces Final Results and Expiration of Exchange Offers |
| 23 Dec 2025 | Pengumuman | Bausch + Lomb to Participate in the 44th Annual J.P. Morgan Healthcare Conference |
| 17 Dec 2025 | Pengumuman | Bausch + Lomb Announces Two Board of Directors Appointments |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |